SCHX vs XLY: 9% overlap
Schwab U.S. Large-Cap ETF and Consumer Discretionary Select Sector SPDR Fund share 9.1% of their portfolios by weight — computed as Σ min(wA, wB) over every holding both funds own.
Different holding dates. These holdings were published about 2 months apart — SCHX as of 2026-05-31, the rest through 2026-07-23. Each fund is compared using its most recent file, so any trading in between shows up as a difference.
You would hold two tickers and get the diversification of 1.9. Two funds that shared nothing would score 2.0; two identical funds score 1.0.
Top shared holdings
SCHX and XLY hold 43 of the same securities. The ten contributing most to the overlap figure:
| Holding | in SCHX | in XLY | Δ |
|---|---|---|---|
| AMZN | 3.9% | 23.5% | 19.6% |
| TSLA | 1.8% | 16.1% | 14.3% |
| HD | 0.5% | 5.8% | 5.3% |
| MCD | 0.3% | 4.4% | 4.1% |
| TJX | 0.3% | 4.3% | 4.0% |
| BKNG | 0.2% | 3.6% | 3.4% |
| LOW | 0.2% | 3.0% | 2.9% |
| SBUX | 0.2% | 3.2% | 3.0% |
| MAR | 0.1% | 2.1% | 2.0% |
| GM | 0.1% | 2.0% | 1.8% |
Where SCHX and XLY differ
Sector weights as a share of each fund, ordered by the size of the gap rather than the size of the sector — two funds that overlap heavily still usually diverge somewhere.
| Sector | SCHX | XLY | Δ |
|---|---|---|---|
| Consumer Discretionary | 9.4% | 99.9% | −90.5pp |
| Information Technology | 36.8% | 0.0% | +36.8pp |
| Financials | 10.9% | 0.0% | +10.9pp |
| Communication Services | 10.1% | 0.0% | +10.1pp |
| Industrials | 8.2% | 0.0% | +8.2pp |
| Health Care | 8.1% | 0.0% | +8.1pp |
| Consumer Staples | 4.4% | 0.0% | +4.4pp |
| Unclassified | 3.4% | 0.0% | +3.4pp |
Δ is SCHX minus XLY, in percentage points. Sector data is not published by every issuer, so “Unclassified” is a real category rather than a gap in the table.
What each fund holds alone
90.8% of SCHX by weight, held in no part of XLY.
4.4% of XLY by weight, held in no part of SCHX.
A large count with a small weight is the usual shape: the positions one fund adds are typically its smallest ones.
Concentration and cost
| SCHX | XLY | |
|---|---|---|
| Top 10 holdings | 37.3% | 68.0% |
| Positions held | 750 | 49 |
| Cost per $10,000 held, per year | $3 | $8 |
Cost is the expense ratio applied to $10,000; it excludes any brokerage commission, bid-ask spread or tax consequence. Figures are facts about the funds, not a suggestion about which to hold.
Frequently asked
How much do SCHX and XLY overlap?
SCHX and XLY overlap 9.1% by portfolio weight — largely distinct portfolios. They share 43 holdings. The figure comes from current issuer holdings files (SCHX as of 2026-05-31, XLY as of 2026-07-23).
How is the overlap between SCHX and XLY calculated?
As the sum of the smaller weight in each fund, over every holding both funds own: Σ min(wA, wB). If SCHX holds a stock at 6% and XLY holds the same stock at 4%, 4% counts as shared. The result is bounded between 0% and 100%, and it is computed after looking through any fund-of-funds to the underlying holdings.
Is it redundant to hold both SCHX and XLY?
That depends on your goals — we state facts, not advice. At 9.1% overlap, each fund still contributes meaningfully distinct exposure.
What does SCHX own that XLY doesn't?
SCHX holds 750 positions and XLY holds 49; 706 of SCHX's positions don't appear in XLY at all, and they are 90.8% of SCHX by weight.
You probably hold more than two funds
This page compares SCHX and XLY. Paste your whole portfolio — brokerage, 401(k), IRA — and see the overlap across every fund at once, plus what you actually own underneath them and your own Effective Funds number. Free, no account, nothing stored.
X-ray my portfolio — free →Watch SCHX vs XLY
We re-read both funds’ published holdings every weeknight. Leave an address and we'll tell you when what's inside actually changes.
Not sending yet — email alerts are built but switched off, and you'll be among the first when they turn on. No spam, one-click unsubscribe.
Related comparisons
Sources: issuer holdings files, SCHX as of 2026-05-31, XLY as of 2026-07-23. Weights are fractions of each fund. Diagnostics, not advice.